Laidlaw Starts Rexahn Pharmaceuticals Inc. (RNN) at Buy, PT $3.50
Tweet Send to a Friend
Laidlaw initiated coverage on Rexahn Pharmaceuticals Inc. (NYSE: RNN) with a Buy rating and a price target of $3.50. Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
